Daiki Murata

Hiroshima, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma.

CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma.

Journal: Anticancer research

Published: August 02, 2021

P53 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma.

P53 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma.

Journal: Anticancer research

Published: July 02, 2021

Erratum: Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapy.

Erratum: Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapy.

Journal: Molecular and clinical oncology

Published: June 28, 2021

Postoperative Inguinal Hernia after Robot-Assisted Radical Prostatectomy with Prevention Technique Using Spermatic Cord Isolation

Postoperative Inguinal Hernia after Robot-Assisted Radical Prostatectomy with Prevention Technique Using Spermatic Cord Isolation

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: May 06, 2021

ROBOT-ASSISTED RADICAL CYSTECTOMY AT HIROSHIMA CITY ASA HOSPITAL -COMPARISON WITH LAPAROSCOPIC RADICAL CYSTECTOMY

ROBOT-ASSISTED RADICAL CYSTECTOMY AT HIROSHIMA CITY ASA HOSPITAL -COMPARISON WITH LAPAROSCOPIC RADICAL CYSTECTOMY

Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology

Published: January 01, 2021

Outcomes of Laparoscopic Radical Prostatectomies by a Single Surgeon Alternating Operating Position

Outcomes of Laparoscopic Radical Prostatectomies by a Single Surgeon Alternating Operating Position

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: September 04, 2020

Significance of timing of therapeutic line on effectiveness of nivolumab for metastatic renal cell carcinoma.

Significance of timing of therapeutic line on effectiveness of nivolumab for metastatic renal cell carcinoma.

Journal: Current urology

Published: May 13, 2020

Prediction of early progression of metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitor.

Prediction of early progression of metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitor.

Journal: Current urology

Published: March 16, 2020

Second Transurethral Resection (TUR) for Bladder Cancer Diagnosed with High Grade pT1 by Initial TUR Under Narrow Band Imaging

Second Transurethral Resection (TUR) for Bladder Cancer Diagnosed with High Grade pT1 by Initial TUR Under Narrow Band Imaging

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: January 15, 2020

Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapy.

Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapy.

Journal: Molecular and clinical oncology

Published: October 12, 2019

C-reactive protein can be used to predict the therapeutic effects of nivolumab in patients with metastatic renal cell carcinoma.

C-reactive protein can be used to predict the therapeutic effects of nivolumab in patients with metastatic renal cell carcinoma.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: August 02, 2019

Robot-Assisted Partial Nephrectomy for Renal Tumor ≤7 cm in Diameter

Robot-Assisted Partial Nephrectomy for Renal Tumor ≤7 cm in Diameter

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: March 05, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026